GSK (GLAXF)

AI Score

Unlock

17.98

-0.48 (-2.60%)

At close: Apr 24, 2025, 3:24 PM

GSK Balance Sheet Statement

Financials in GBP. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	3.69B	2.94B	3.72B	4.27B	6.29B	4.71B	3.87B	3.83B	4.9B
Short-Term Investments	21M	2.25B	4.15B	61M	78M	79M	84M	78M	89M
Long-Term Investments	1.21B	769M	-2.61B	2.15B	3.35B	2.07B	1.47B	1.02B	1.16B
Other Long-Term Assets	1.93B	8.06B	5.35B	1.75B	1.12B	1.2B	1.73B	1.5B	1.29B
Receivables	n/a	-190M	7.12B	8.03B	7.26B	7.15B	5.18B	4.67B	4.62B
Inventory	5.67B	5.5B	5.15B	5.78B	6B	5.95B	5.48B	5.56B	5.1B
Other Current Assets	7.22B	7.8B	7.6B	8.44B	7.72B	1.61B	1.98B	1.77B	2.01B
Total Current Assets	17B	18.64B	20.77B	18.67B	20.25B	19.49B	16.93B	15.91B	16.71B
Property-Plant & Equipment	10.07B	9.96B	9.62B	10.67B	11.01B	11.31B	11.06B	10.86B	10.81B
Goodwill & Intangibles	22.5B	21.58B	21.36B	40.63B	40.42B	41.52B	22.99B	23.3B	24.74B
Total Long-Term Assets	42.47B	40.36B	39.38B	60.43B	60.18B	60.2B	41.14B	40.47B	42.37B
Total Assets	59.46B	59.01B	60.15B	79.1B	80.43B	79.69B	58.07B	56.38B	59.08B
Account Payables	3.46B	3.72B	3.87B	4.54B	4.36B	14.94B	14.04B	20.97B	11.96B
Deferred Revenue	n/a	n/a	1.31B	1.56B	1.82B	1.44B	1.82B	1.7B	2.35B
Short-Term Debt	2.18B	2.66B	3.79B	3.4B	3.5B	6.92B	5.79B	2.83B	4.13B
Other Current Liabilities	14.76B	13.69B	14.1B	14.53B	13.11B	755M	837M	1.08B	561M
Total Current Liabilities	21.7B	21.07B	22.81B	23.67B	22.15B	24.05B	22.49B	26.57B	19B
Long-Term Debt	13.7B	14.15B	16.19B	19.76B	22.54B	23.59B	20.27B	14.26B	14.66B
Other Long-Term Liabilities	9.5B	9.94B	10.21B	9.88B	14.05B	13.7B	11.63B	10.66B	18.52B
Total Long-Term Liabilities	24.68B	25.14B	27.24B	34.09B	37.48B	37.28B	31.9B	26.32B	35.12B
Total Liabilities	46.38B	46.21B	50.05B	57.76B	59.62B	61.34B	54.39B	52.89B	54.12B
Total Debt	16.99B	18.02B	20.99B	24.17B	27.15B	30.51B	26.06B	17.09B	18.79B
Common Stock	1.35B	1.35B	1.35B	1.35B	1.35B	1.35B	1.34B	1.34B	1.34B
Retained Earnings	7.8B	7.24B	4.36B	7.94B	6.75B	5.11B	-2.14B	-6.48B	-5.39B
Comprehensive Income	n/a	n/a	-48M	642M	1.55B	641M	n/a	n/a	n/a
Shareholders Equity	13.67B	13.35B	10.6B	15.05B	14.59B	11.98B	4.36B	-68M	1.12B
Total Investments	1.23B	1.22B	1.54B	2.21B	3.42B	2.15B	1.56B	1.1B	1.25B